Product Name: Human MMP-9 Antibody (Andecaliximab, Research Use)
Catalog Number: NBR-0248
Target Name: MMP-9
Trade Name: Andecaliximab
Antibody Drug Description: Andecaliximab is an experimental humanized monoclonal antibody designed for the treatment of cancer and inflammatory diseases. Phase II and phase III trials for gastric cancer or gastroesophageal junction adenocarcinoma completed in 2019. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: MMP-9
Synonyms: CLG4B
Target Description: Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption (By similarity).
Ensembl: ENSG00000100985
Uniprot: P14780